or 12.14% when compared to that of Baht 23.39 million in the second quarter of the year 2018. 3. Net Profit In the second quarter of the year 2019, the operating profit of the Company and its
change of scoring criteria effective this year despite an increase of average number of registered patients to 176,554 from 164,812 person yoy. Operation : Consolidated Profit & Loss Statement 3Q 3Q % 9
interest and taxes (EBIT) 32.79 107.16 (74.37) (69.40) Financial costs 0.72 0.13 0.59 453.85 Income tax expenses 2.86 20.81 (17.95) (86.26) Net profit 29.21 86.21 (57.00) (66.12) Earnings before interest
115.04 -4.98 329.68 299.29 10.15 Selling expenses 50.13 48.46 3.44 57.80 -13.27 157.01 137.38 14.29 Administrative expenses 59.19 55.13 7.37 57.25 3.40 172.67 161.91 6.65 Earnings before interest and taxes
financial statements for the three-month period ended September30, 2019. The Group's sales and net profit totaled Bt3,088.3 million and Bt255.1 million, respectively, compared to Bt3,690.4 million and
efficient of collection team, the Company’s net profit performance in 2018 reached to its highest in corporate history with net profit of 505.5 million Baht, increased at 27.6% from the previous year. The
Microsoft Word - MD&A 3Q17 EN November 14, 2017 To President, The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent
Microsoft Word - MD&A FY17 EN (1) February 26, 2018 To President, The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20
2018, the Company had gain on exchange rate of THB 18.58 million. Cost of Sales and Gross Profit The Company’s cost of sales is mainly consisted of raw material cost which is equal to approximately 85